Exact Mass: 564.4025826

Exact Mass Matches: 564.4025826

Found 28 metabolites which its exact mass value is equals to given mass value 564.4025826, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

DG(10:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C33H56O7 (564.4025826)


DG(10:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/10:0/0:0)

(2S)-2-(decanoyloxy)-3-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C33H56O7 (564.4025826)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-3-(decanoyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C33H56O7 (564.4025826)


DG(10:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/10:0)

(2S)-3-(decanoyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C33H56O7 (564.4025826)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (5S,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C33H56O7 (564.4025826)


DG(10:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C33H56O7 (564.4025826)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C33H56O7 (564.4025826)


DG(10:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C33H56O7 (564.4025826)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C33H56O7 (564.4025826)


DG(10:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C33H56O7 (564.4025826)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C33H56O7 (564.4025826)


DG(10:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C33H56O7 (564.4025826)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(10:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C33H56O7 (564.4025826)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/10:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/10:0/0:0)

C33H56O7 (564.4025826)


   

DG(10:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(10:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C33H56O7 (564.4025826)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/10:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/10:0)

C33H56O7 (564.4025826)


   

DG(10:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(10:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C33H56O7 (564.4025826)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/10:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/10:0/0:0)

C33H56O7 (564.4025826)


   

DG(10:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(10:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C33H56O7 (564.4025826)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/10:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/10:0)

C33H56O7 (564.4025826)


   

DG(10:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(10:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C33H56O7 (564.4025826)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/10:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/10:0/0:0)

C33H56O7 (564.4025826)


   

DG(10:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(10:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C33H56O7 (564.4025826)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/10:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/10:0)

C33H56O7 (564.4025826)


   
   
   

7-hydroxy-8-[5-hydroxy-8-(3-hydroxy-4,6-dimethylnon-6-en-2-yl)-10-methoxy-3,9-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl]-6-methylnona-2,4-dienal

7-hydroxy-8-[5-hydroxy-8-(3-hydroxy-4,6-dimethylnon-6-en-2-yl)-10-methoxy-3,9-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl]-6-methylnona-2,4-dienal

C33H56O7 (564.4025826)


   

(2e,4z)-7-hydroxy-8-[(2s,3s,5s,6r,8r,9r,10r)-5-hydroxy-8-[(6e)-3-hydroxy-4,6-dimethylnon-6-en-2-yl]-10-methoxy-3,9-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl]-6-methylnona-2,4-dienal

(2e,4z)-7-hydroxy-8-[(2s,3s,5s,6r,8r,9r,10r)-5-hydroxy-8-[(6e)-3-hydroxy-4,6-dimethylnon-6-en-2-yl]-10-methoxy-3,9-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl]-6-methylnona-2,4-dienal

C33H56O7 (564.4025826)